CellaVision AB - Asset Resilience Ratio

Latest as of December 2022: -0.58%

CellaVision AB (CEVI) has an Asset Resilience Ratio of -0.58% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of CellaVision AB for a breakdown of total debt and financial obligations.

Liquid Assets

Skr-5.15 Million

≈ $-554.44K USD Cash + Short-term Investments

Total Assets

Skr891.75 Million

≈ $95.97 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2022)

This chart shows how CellaVision AB's Asset Resilience Ratio has changed over time. See net assets of CellaVision AB for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down CellaVision AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of CellaVision AB.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr-5.15 Million	-0.58%
Total Liquid Assets	Skr-5.15 Million	-0.58%

Asset Resilience Insights

Limited Liquidity: CellaVision AB maintains only -0.58% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

CellaVision AB Industry Peers by Asset Resilience Ratio

Compare CellaVision AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Double Medical Technology Inc SHE:002901	Medical Devices	7.79%
Beijing Wandong Medical Technology Co Ltd SHG:600055	Medical Devices	4.92%
Sinocare Inc SHE:300298	Medical Devices	3.53%
MODULIGHT OY EO 1 F:78W	Medical Devices	22.31%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.39%
Theradiag SA PA:ALTHE	Medical Devices	15.59%
Nova EYE Medical Ltd AU:EYE	Medical Devices	11.08%

Annual Asset Resilience Ratio for CellaVision AB (2012–2022)

The table below shows the annual Asset Resilience Ratio data for CellaVision AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	-0.58%	Skr-5.15 Million ≈ $-554.44K	Skr891.75 Million ≈ $95.97 Million	+2.06pp
2021-12-31	-2.64%	Skr-21.79 Million ≈ $-2.34 Million	Skr825.21 Million ≈ $88.81 Million	-0.06pp
2020-12-31	-2.58%	Skr-17.25 Million ≈ $-1.86 Million	Skr668.02 Million ≈ $71.89 Million	+0.21pp
2019-12-31	-2.79%	Skr-17.93 Million ≈ $-1.93 Million	Skr641.71 Million ≈ $69.06 Million	-16.83pp
2013-12-31	14.03%	Skr26.47 Million ≈ $2.85 Million	Skr188.57 Million ≈ $20.29 Million	+13.86pp
2012-12-31	0.18%	Skr318.00K ≈ $34.22K	Skr178.56 Million ≈ $19.22 Million	--

pp = percentage points

About CellaVision AB

ST:CEVI Sweden Medical Devices

Market Cap

$311.10 Million

Skr2.89 Billion SEK

Market Cap Rank

#14799 Global

#231 in Sweden

Share Price

Skr121.20

Change (1 day)

-1.14%

52-Week Range

Skr120.20 - Skr200.00

All Time High

Skr478.48